New option for liver cancer
The new dual immunotherapy regimen significantly improved overall survival compared with standard treatment in patients with advanced inoperable hepatocellular carcinoma. More at the link!
The new dual immunotherapy regimen significantly improved overall survival compared with standard treatment in patients with advanced inoperable hepatocellular carcinoma. More at the link!